Mirae Asset Global Investments
CVAC

Mirae Asset Global Investments’s CureVac CVAC Stock Holding History

Mirae Asset Global Investments’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,705
Closed -$46.9K – 1659
2025
Q3 		$46.9K Buy
8,705
+7
+0.1% +$38 ﹤0.01% 1356
2025
Q2 		$47.2K Buy
8,698
+1,191
+16% +$4.72K ﹤0.01% 1269
2025
Q1 		$22.4K Buy
7,507
+31
+0.4% +$108 ﹤0.01% 1381
2024
Q4 		$23.7K Sell
7,476
-637
-8% -$1.84K ﹤0.01% 1396
2024
Q3 		$24.3K Buy
8,113
+1,416
+21% +$4.67K ﹤0.01% 1406
2024
Q2 		$22.5K Buy
+6,697
New +$21.9K ﹤0.01% 1365
2023
Q3 		– Sell
-15,342
Closed -$160K – 2584
2023
Q2 		$160K Buy
15,342
+3,806
+33% +$34K ﹤0.01% 2405
2023
Q1 		$80.4K Sell
11,536
-1,110
-9% -$9.68K ﹤0.01% 2475
2022
Q4 		$76.3K Buy
+12,646
New +$93.4K ﹤0.01% 2489

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Mirae Asset Global Investments's CVAC Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of CureVac (CVAC) in Q4 2025, closing a stake of 8,705 shares — an estimated $46.9K sold.

Mirae Asset Global Investments first reported a position in CVAC in Q4 2022 and held it in 9 quarters. The position peaked at $160K in Q2 2023. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 8,705 CureVac shares in Q4 2025, an estimated $46.9K.
  • Mirae Asset Global Investments first reported a position in CureVac in Q4 2022 and held it in 9 quarters.
  • Mirae Asset Global Investments's CureVac position peaked at $160K in Q2 2023.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.